Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
According to Benzinga Pro data, during Q2, 908 Devices (NASDAQ:MASS) posted sales of $11.11 million. Earnings were up 13.98%, but 908 Devices still reported an overall loss of $8.10 million.